10-Q quarterly report · filed Nov 10, 2026

Anterix Inc. (ATEX) Q3 2026 10-Q Quarterly Report

Short answer

Anterix Inc. (ATEX) filed its Q3 2026 10-Q quarterly report on Nov 10, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $2M (up 26.2% year over year) with net income of −$5M.

Q3 2026 key financials · XBRL

Revenue
$2M
+26.2% YoY · +0.0% QoQ
Net income
−$5M
−109.3% YoY · −2180.4% QoQ
Operating margin
-291.6%
EPS (diluted)
−$0.26
−109.1% YoY · −2700.0% QoQ

Source: XBRL data from the Anterix Inc. (ATEX) Q3 2026 10-Q on SEC EDGAR. USD.

Anterix Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $2.0M, up 26% YoY from $1.6M, driven by TECO license delivery
  • Net loss $5.0M vs net income $53.5M YoY, reflecting lower intangible-asset gains
  • Spectrum revenue best-performing line, $2.0M vs $1.6M; no segment data disclosed
  • Cash and equivalents $107.5M; six-month operating cash use $4.1M vs $1.7M
  • Capital deployment: $12.2M investing outflow, $22.2M financing inflow from $23.2M option exercises
  • Outlook: liquidity sufficient for at least 12 months, with potential additional capital needs and regulatory headwinds

Risk Factors

  • No material changes from the 2026 Annual Report’s disclosed risk factors
  • Unknown or currently immaterial risks could adversely affect results of operations or financial condition
  • Undisclosed carried-forward risks may materially affect Anterix’s common stock valuation

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Anterix Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.